Invention Grant
- Patent Title: Selective BACE1 inhibitors
-
Application No.: US15135580Application Date: 2016-04-22
-
Publication No.: US10011610B2Publication Date: 2018-07-03
- Inventor: David Michael Remick , Simon James Richards , Adam Jan Sanderson
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Nelsen L. Lentz
- Main IPC: C07D513/04
- IPC: C07D513/04 ; C07C309/04 ; C07C309/31
Abstract:
The present invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20160318953A1 Selective BACE1 Inhibitors Public/Granted day:2016-11-03
Information query
